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EDITORIAL 
 
Documented evidences available from both 
developed and developing countries reveal 
that the number of clinical imaging 
procedures and instruments have continued 
to increase over the past decades, confirming 
the increasing demand for these clinical 
imaging modalities (1-5). Accordingly, 
concerns about over-utilization and 
inappropriate use in imaging have been 
raised, and consequently medical authorities 
and clinicians who were slow to respond to 
spiraling costs of cardiac imaging years ago, 
now recognize the need to promote 
appropriate and cost-conscious use of 
imaging, mainly through the development of 
appropriateness criteria and guidelines, 
which are focused on eliminating 
unnecessary testing to decrease health care 
costs (6, 7). 
As an important section of clinical imaging, 
nuclear medicine imagings have grown 
tremendously over the past 50 years and they 
now play an important role in all medical 
disciplines (2). Single-photon Emission 
Computed Tomography Myocardial 
Perfusion Imaging (SPECT-MPI) is one of 
the most widely used procedures of nuclear 
medicine that is usually applied to detect 
perfusion abnormalities and foster improved 
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detection of patients at-risk (8). As similar to 
other advanced clinical imaging modalities, 
the number of myocardial perfusion scans 
performed annually in developed countries 
has increased (5, 8). For example, the 
number in Ontario (Canada) has increased 
by 101% between 1996/1997 and 2005/2006 
(3) and also in Germany the number of 
myocardial perfusion scintigraphies actually 
increased between 2005 and 2006, despite 
the emergence of competing methods (9). 
The same figure is available from both the 
United States and other European countries: 
since 1998, the rates for SPECT-MPIs have 
increased from 10% to 30% per year (5, 6). 
Regarding these features, countries like 
United States, Canada, most western 
European countries, Australia, and Japan 
have been reported to have high or 
moderate-high nuclear cardiology utilization 
(8).  
However, dramatic growth in the physicians’ 
request of imaging modalities –such as 
SPECT-MPI- and their dependence to 
clinical imaging for diagnosis of the diseases 
(10, 11) has led authorities to question the 
appropriateness of the referrals and consider 
strategies to constrain further diagnostic test 
growth. In this regard, special attention has 
been paid to cardiovascular diagnostic 
procedures due to their clinical importance 
and high costs: numerous studies are 
available to evaluate the contributing factors 
in physicians’ decision to refer a patient for 
cardiac catheterization (12-15) or cardiac 
computed tomography (16). 
Although emphases have been made by 
authorities in the American College of 
Cardiology Foundation (ACCF) and the 
American Society of Nuclear Cardiology 
(ASNC) (17, 18), appropriateness of MPI 
referrals in developing countries has not 
been previously studied extensively and also 
just few studies have been reported from the 
developed nations (19-21).  
Particularly in developing nations, this is 
mainly because governmental endeavors to 
establish a health technology assessment unit 
are still in the early stages (1, 22). 
  
Appropriateness of referrals in IRAN 
Recently we conducted a study (23) to 
describe the ordering practices of physicians 
and appropriateness of MPI referrals in 
multiple clinical sites of Iran (as a 
developing country), by use of ACCF/ASNC 
Guidelines for the Clinical Use of Cardiac 
Radionuclide Imaging as the major 
background reference (24, 25).  
For the study purpose, we convened a panel, 
consisted of two cardiologists, one internist, 
and one nuclear medicine physician. The 
moderator of the session presented each case 
in the face-to-face meeting. Then the 
panelists were invited to judge 
appropriateness of SPECT-MPI for each 
patient on a 9-point scale, on which scores of 
1 to 3 denoted inappropriate referral (no 
benefit of SPECT-MPI), 4 to 6 denoted 
uncertainty about use (when harms and 
benefits were judged as approximately 
equal, or when the best available evidence 
did not support a judgment either way), and 
7 to 9 denoted appropriate use (benefits were 
judged to outweigh harms) (26). Calculating 
the mean of scores from four panelists, the 
mean of 7-9 was considered appropriate (A), 
3.1-6.9 uncertain (U), and 1-3 inappropriate 
(I).  
At the next step, panelists were asked to 
independently assign a specific indication 
(scenario), whenever possible in accordance 
with ACCF/ASNC appropriateness scenarios 
for each case. In this line, SPECT-MPI 
studies were then classified into appropriate, 
inappropriate, uncertain, or unclassified 
(when the consensus of the panelists was 
that the case did not matched to any of the 
presented scenarios of ACCF/ASNC 
Guidelines) (26).  
Two hundred and ninety one patients (167 
female, 124 male, mean age of 55.3±10.3 
years) entered the study. The level of 
appropriateness of referrals for SPECT-MPI 
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was judged appropriate for 56.0%, uncertain 
for 33.3% and inappropriate for 10.7% 
patients (Fig. 1). Based on the ACCF/ASNC 
appropriateness criteria, SPECT-MPI testing 
were judged appropriate for 72.5%, 
uncertain for 12.4% and inappropriate for 
11.0% of referrals (26). Panelists had 
consensus that in 4.1% referrals, the case do 
not matched to any of the 52 presented 
scenarios of 2005 ACCF/ASNC Guidelines 
(unclassified).  
 
 
Fig. 1. The distribution of referrals based on the nine-
point scale rating of the panel. 
(* For each referral, a mean score of 1 to 3 was 
defined as “inappropriate”, 3.1 to 6.9 as “uncertain”, 
and 7 to 9 as “appropriate”. The agreement among the 
observers was good; ICC: 0.68; P < 0.001). 
 
 
Regarding the level of appropriateness of 
referrals, there was no significant difference 
between hospital-based governmental and 
private free-standing nuclear medicine 
centers. SPECT-MPIs were interpreted as 
normal in 69.8% and abnormal in 30.2% 
patients. A higher percentage of referrals 
with inappropriate indications were normal 
as compared to the appropriate referrals (26).  
 
Good news for Iranian medical community 
Driven by the monetary interest of free-
market financing structure of health care 
providers, developing countries have been 
experiencing a rapid expansion and fast 
growth in conventional nuclear medicine 
technology (2). The number of conventional 
nuclear medicine facilities in some of these 
countries has risen by more than 2.2 fold in 
less than a decade, and nuclear cardiology 
applications remain one of the most 
prevalent requested procedures of this 
technology (10). These statistics have caused 
a remarkable apprehension and debate on the 
ordering habits of cardiologists, whether this 
explosion of nuclear cardiology technology 
to developing countries is justified, logical 
and clinically needed. 
According to our study findings, a high 
percentage of SPECT-MPI procedures in 
Iran are being done with appropriate 
indications, comparable with that found in 
developed (18, 19, 27) and other developing 
nations (23), where 64-87% of studies were 
deemed appropriate. This is good news for 
developing countries, since many health 
authorities as concerned that a remarkable 
portion of the current referrals are not 
“efficient”. Fragile structure of insurance 
companies aggravates these concerns (2), 
which seems to be supported by no 
documented evidence.  
Although up to a quarter of referrals are 
ordered with uncertain or inappropriate 
indications, our study provides an evidence 
for the fact that SPECT-MPI ordering 
practices in our developing community 
largely parallel the ACCF/ASNC 
recommendations (26).   
 
Strengths and weaknesses of appropriateness 
criteria 
Similar to previous reports (18, 19, 27), our 
study support the assumption that coming 
into clinical practice, the appropriateness 
criteria encounter some limitations: The 
supporting evidences originate from registry 
data and expert opinion. Although these 
evidences are applicable to a wide variety of 
(but not all) the clinical situations, 
occasionally deal with cut-and-dried 
situations cannot cover all the real-life 
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clinical scenarios meet by cardiologists, 
which are usually complex (28). These 
recommendations must continue to be 
updated and refined to ensure their coverage 
on all possible clinical scenarios encountered 
in daily practice of referring physicians. 
However, ACCF/ASNC criteria are strong 
enough to be considered as the basis for 
reimbursement for SPECT-MPI referrals. 
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